Meeting II

January 29–30, 2001

The Foundry Building

1055 Thomas Jefferson Street, NW

Washington, DC

Meeting Objectives

  • Review several completed studies of anthrax vaccine safety and efficacy

  • Evaluate knowledge of vaccine components

  • Define needs for additional information gathering

  • Plan future meetings


Monday, January 29, 2001

12:00 p.m.

Open Session

A review of some of the studies of the anthrax vaccine


The CDC Observational Study

Dr. Juli Clifford, Center for Biologics Evaluation and Research, FDA


Components of the Anthrax Vaccine Absorbed and Contrast with Merck Vaccine

Dr. Robert Myers, BioPort Corporation


Working lunch


Field Evaluation of a Human Anthrax Vaccine

Dr. Stanley Plotkin


Ft. Detrick Multi-Dose, Multi-Vaccine Safety Studies

LTC Phillip Pittman, U.S. Army Medical Research Institute of Infectious Diseases


Ft. Detrick Special Immunization Program

LTC Phillip Pittman

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement